Bridgeway Capital Management’s HCW Biologics HCWB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-868
| Closed | -$15.5K | – | 1210 |
|
|
2024
Q4 | $15.5K | Sell |
868
-1,250
| -59% | -$22.3K | ﹤0.01% | 1187 |
|
|
2024
Q3 | $45.7K | Hold |
2,118
| – | – | ﹤0.01% | 1217 |
|
|
2024
Q2 | $54.8K | Hold |
2,118
| – | – | ﹤0.01% | 1206 |
|
|
2024
Q1 | $141K | Hold |
2,118
| – | – | ﹤0.01% | 1164 |
|
|
2023
Q4 | $104K | Buy |
2,118
+53
| +3% | +$2.6K | ﹤0.01% | 1234 |
|
|
2023
Q3 | $158K | Hold |
2,065
| – | – | ﹤0.01% | 1137 |
|
|
2023
Q2 | $179K | Hold |
2,065
| – | – | ﹤0.01% | 1159 |
|
|
2023
Q1 | $114K | Buy |
2,065
+250
| +14% | +$13.8K | ﹤0.01% | 1210 |
|
|
2022
Q4 | $139K | Hold |
1,815
| – | – | ﹤0.01% | 1165 |
|
|
2022
Q3 | $166K | Hold |
1,815
| – | – | ﹤0.01% | 1172 |
|
|
2022
Q2 | $160K | Buy |
1,815
+400
| +28% | +$35.3K | ﹤0.01% | 1138 |
|
|
2022
Q1 | $155K | Buy |
1,415
+250
| +21% | +$27.4K | ﹤0.01% | 1208 |
|
|
2021
Q4 | $108K | Buy |
+1,165
| New | +$108K | ﹤0.01% | 1211 |
|